Please assess the completion status of the following clinical trial:

Trial Title: Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age according to approved label and physician discretion~* Type 2 diabetes including newly-diagnosed subjects who have never received insulin or an insulin analogue before~Exclusion Criteria:~* Subjects who previously enrolled in this study~* Subjects who are unlikely to comply with protocol requirements~* Hypersensitivity to biphasic insulin aspart or to any of the excipients~* Women who are pregnant, breast feeding or have the intention of becoming pregnant within next 12 months

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: None): biphasic insulin aspart

Based on this trial design, predict the completion outcome and termination type (if applicable).